Airflusal Forspiro is a prescription medication used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a combination inhaler that contains two active ingredients: fluticasone propionate, a corticosteroid that reduces inflammation in the lungs, and salmeterol, a long-acting beta2-adrenergic agonist that helps to relax the muscles around the airways in the lungs, making it easier to breathe. This combination works together to improve lung function, prevent symptoms such as wheezing, coughing, shortness of breath, and chest tightness, and reduce the number of flare-ups or exacerbations in patients with asthma or COPD. Airflusal Forspiro is typically used as a long-term treatment and is administered through inhalation, allowing the medication to directly reach the lungs for effective relief of symptoms.